Robert Klepacki

Robert Klepacki, PharmD, currently serves as the Senior Director and Tumor Commercialization Lead for Solid Tumor ADC at GSK since July 2025. Prior to this role, Robert held multiple leadership positions at AstraZeneca from May 2017 to July 2025, including US Marketing Head and Global Commercial Head for Hematology, along with various director roles focused on marketing, analytics, and R&D strategy in the hematology sector. At Bristol Myers Squibb, Robert worked from July 2014 to May 2017 as Manager of Clinical Trial Analytics and Portfolio Analyst in R&D Strategy. Robert began the career as a Pharmacist at Target from May 2010 to May 2015, transitioning from a Pharmacy Intern through a corporate rotational program. Academic qualifications include a Doctorate of Pharmacy from Temple University and a Bachelor of Science in Biology from Washington College.